FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Drug Test Anal / In vivo metabolism of the designer anabolic steroid hemapoli...
Drug testing and analysis2020; 12(6); 752-762; doi: 10.1002/dta.2769

In vivo metabolism of the designer anabolic steroid hemapolin in the thoroughbred horse.

Abstract: Hemapolin (2α,3α-epithio-17α-methyl-5α-androstan-17β-ol) is a designer steroid that is an ingredient in several "dietary" and "nutritional" supplements available online. As an unusual chemical modification to the steroid A-ring could allow this compound to pass through antidoping screens undetected, the metabolism of hemapolin was investigated by an in vivo equine drug administration study coupled with GC-MS analysis. Following administration of synthetically prepared hemapolin to a thoroughbred horse, madol (17α-methyl-5α-androst-2-en-17β-ol), reduced and dihydroxylated madol (17α-methyl-5α-androstane-2β,3α,17β-triol), and the isomeric enone metabolites 17β-hydroxy-17α-methyl-5α-androst-3-en-2-one and 17β-hydroxy-17α-methyl-5α-androst-2-en-4-one, were detected and confirmed in equine urine extracts by comparison with a library of synthetically derived reference materials. A number of additional madol derivatives derived from hydroxylation, dihydroxylation, and trihydroxylation were also detected but not fully identified by this approach. A yeast cell-based androgen receptor bioassay of available reference materials showed that hemapolin and many of the metabolites identified by this study were potent activators of the equine androgen receptor. This study reveals the metabolites resulting from the equine administration of the androgen hemapolin that can be incorporated into routine GC-MS antidoping screening and confirmation protocols to detect the illicit use of this agent in equine sports.
© 2020 John Wiley & Sons, Ltd.
Get Full Text
Publication Date: 2020-02-04 PubMed ID: 31950580DOI: 10.1002/dta.2769Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explores the metabolism of Hemapolin, a designer steroid often used in dietary supplements, in thoroughbred horses. The study reveals the metabolites that result from the equine administration of Hemapolin, which can be leveraged for GC-MS antidoping tests to detect its illicit use in horse racing.

About Hemapolin

  • Hemapolin (2α,3α-epithio-17α-methyl-5α-androstan-17β-ol) is a designer steroid found in several dietary and nutritional supplements sold online.
  • Due to its unusual chemical modification to the steroid A-ring, this compound can slip through doping detection screens unnoticed.

Investigating Hemapolin Metabolism

  • The research team performed an in vivo drug administration study on a thoroughbred horse to investigate Hemapolin metabolism followed by Gas Chromatography-Mass Spectrometry (GC-MS) analysis.
  • Synthetically prepared Hemapolin was administered to a thoroughbred horse for this study.

The Metabolites

  • After administration, several metabolites including madol, reduced and dihydroxylated madol, and the isomeric enone metabolites were detected in the equine urine extracts.
  • The detection was confirmed by comparison with a library of synthetically derived reference materials.
  • A number of additional madol derivatives derived from hydroxylation, dihydroxylation, and trihydroxylation were also detected, but their identities were not fully established in this study.

Endocrine Activity

  • A yeast cell-based androgen receptor bioassay of available reference materials was conducted.
  • The results showed that Hemapolin and many of the metabolites identified by the study were potent activators of the equine androgen receptor.

Impact of the Study

  • The study helps expose the metabolites resulting from the equine administration of the androgen Hemapolin.
  • These findings can be incorporated into regular GC-MS antidoping screening and confirmation protocols to detect the illicit use of Hemapolin in equine sports.

Cite This Article

APA
Waller CC, Weththasinghe SA, McClure L, Cawley AT, Suann C, Suann E, Sutherland E, Cooper E, Heather A, McLeod MD. (2020). In vivo metabolism of the designer anabolic steroid hemapolin in the thoroughbred horse. Drug Test Anal, 12(6), 752-762. https://doi.org/10.1002/dta.2769

Publication

Drug testing and analysis
ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 12
Issue: 6
Pages: 752-762

Researcher Affiliations

Waller, Christopher C
  • Research School of Chemistry, Australian National University, Canberra, Australia.
Weththasinghe, Sumudu A
  • Research School of Chemistry, Australian National University, Canberra, Australia.
McClure, Lauren
  • Australian Racing Forensic Laboratory, Racing NSW, Sydney, Australia.
Cawley, Adam T
  • Australian Racing Forensic Laboratory, Racing NSW, Sydney, Australia.
Suann, Craig
  • Australian Racing Forensic Laboratory, Racing NSW, Sydney, Australia.
Suann, Emily
  • Australian Racing Forensic Laboratory, Racing NSW, Sydney, Australia.
Sutherland, Emma
  • Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Cooper, Elliot
  • Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Heather, Alison
  • Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
McLeod, Malcolm D
  • Research School of Chemistry, Australian National University, Canberra, Australia.

MeSH Terms

  • Animals
  • Biotransformation
  • Designer Drugs / metabolism
  • Doping in Sports / methods
  • Gas Chromatography-Mass Spectrometry
  • Horses / metabolism
  • Receptors, Androgen / metabolism
  • Reference Standards
  • Steroids / metabolism
  • Steroids / urine
  • Substance Abuse Detection / methods
  • Testosterone Congeners / metabolism
  • Testosterone Congeners / urine

Grant Funding

  • LP120200444 / Australian Research Council

References

This article includes 34 references
  1. Catlin DH, Ahrens BD, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes’ urine.. Rapid Commun Mass Spectrom 2002;16:1273-1275.
  2. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang Y, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine.. Rapid Commun Mass Spectrom 2004;18:1245-1249.
  3. Sekera MH, Ahrens BD, Chang Y, Starcevic B, Georgakopoulos C, Catlin DH. Another designer steroid: discovery, synthesis, and detection of ‘madol’ in urine.. Rapid Commun Mass Spectrom 2005;19:781-784.
  4. Joseph JF, Parr MK. Synthetic androgens as designer supplements.. Curr Neuropharmacol 2015;13:89-100.
  5. Rahnema CD, Crosnoe LE, Kim ED. Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem.. Andrology 2015;3:150-155.
  6. Waller CC, McLeod MD. A review of designer anabolic steroids in equine sports.. Drug Test Anal 2017;9:1304-1319.
  7. Chew W, Harpp DN. Recent aspects of thiirane chemistry.. Sulfur Rep 1993;15:1-39.
  8. Abbate V, Kicman AT, Evans-Brown M. Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health.. Drug Test Anal 2015;7:609-618.
  9. Akram ON, Bursill C, Desai R. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays.. Anal Chem 2011;83:2065-2074.
  10. Okano M, Sato M, Ikekita A, Kageyama S. Analysis of non-ketoic steroids 17α-methylepithiostanol and desoxymethyl-testosterone in dietary supplements.. Drug Test Anal 2009;1:518-525.
  11. Alvarez-Ginarte YM, Crespo-Otero R, Marrero-Ponce Y. Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues.. Bioorg Med Chem 2008;16:6448-6459.
  12. World Anti-Doping Agency. World Anti-Doping Code International Standard, Prohibited List, January 2019.. 2019.
  13. International Federation of Horseracing Authorities. International Agreement on Breeding, Racing and Wagering, 2019.. 2019.
  14. Armarego WLF, Chai C. Chapter 4 - Purification of organic chemicals.. 2013:103-554.
  15. Murray RW, Singh M. Synthesis of epoxides using dimethyldioxirane: trans-stilbene oxide.. Organic Synth 1997;74:91-97.
  16. Mikula H, Svatunek D, Lumpi D, Glöcklhofer F, Hametner C, Fröhlich J. Practical and efficient large-scale preparation of dimethyldioxirane.. Org Process Res Dev 2013;17:313-316.
  17. Cawley AT, Blakey K, Waller CC. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol.. Drug Test Anal 2016;8:621-632.
  18. Death AK, McGrath KCY, Kazlauskas R, Handelsman DJ. Tetrahydrogestrinone is a potent androgen and progestin.. J Clin Endocrinol Metab 2004;89:2450-2498.
  19. Gauthier J, Poirier D, Ayotte C. Characterization of desoxymethyltestosterone main urinary metabolite produced from cultures of human fresh hepatocytes.. Steroids 2012;77:635-643.
  20. Cabaj JE, Kairys D, Benson TR. Development of a commercial process to produce Oxandrolone.. Org Process Res Dev 2007;11:378-388.
  21. Wharton P, Bohlen D. Communications - hydrazine reduction of α,β-epoxy ketones to allylic alcohols.. J Org Chem 1961;26:3615-3616.
  22. Okano M, Sato M, Kojima A, Kageyama S. Determination of mepitiostane metabolites in human urine by liquid chromatography/tandem mass spectrometry for sports drug testing.. J Pharm Biomed Anal 2015;115:236-244.
  23. Association of Official Racing Chemists. AORC MS Criteria (modified 23 August 2016).. 2016.
  24. Middleditch BS, Vouros P, Brooks CJW. Mass spectrometry in the analysis of steroid drugs and their metabolites: electron-impact-induced fragmentation of ring D.. J Pharm Pharmacol 1973;25:143-149.
  25. Schoene C, Nedderman ANR, Houghton E. Preliminary study of the metabolism of 17α-methyltestosterone in horses utilizing gas chromatography-mass spectrometric techniques.. Analyst 1994;119:2537-2542.
  26. Ichihashi T, Kinoshita H, Shimamura K, Yamada H. Absorption and disposition of epithiosteroids in rats (1): route of administration and plasma levels of epitiostanol.. Xenobiotica 1991;21:865-872.
  27. Ichihashi T, Kinoshita H, Yamada H. Absorption and disposition of epithiosteroids in rats (2): avoidance of first-pass metabolism of mepitiostane by lymphatic absorption.. Xenobiotica 1991;21:873-880.
  28. Kwok WH, Kwok KY, Leung DKK. In vitro metabolism studies of desoxy-methyltestosterone (DMT) and its five analogues, and in vivo metabolism of desoxy-vinyltestosterone (DVT) in horses.. J Mass Spectrom 2015;50:994-1005.
  29. Sobolevsky T, Rodchenkov G. Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control.. Drug Test Anal 2012;4:682-691.
  30. Groves JT, Adhyam DV. Hydroxylation by cytochrome P-450 and metalloporphyrin models. Evidence for allylic rearrangement.. J Am Chem Soc 1984;106:2177-2181.
  31. Tanaka K, Kurihara N, Nakajima M. Oxidative metabolism of tetrachlorocyclohexenes, pentachlorocyclohexenes, and hexachlorocyclohexenes with microsomes from rat liver and house fly abdomen.. Pestic Biochem Physiol 1979;10:79-95.
  32. de Montellano PRO, Voss JJD. Substrate oxidation by cytochrome P450 enzymes.. 2005:183-245.
  33. Oliw EH, Brodowsky ID, Hornsten L, Hamberg M. Bis-allylic hydroxylation of polyunsaturated fatty acids by hepatic monooxygenases and its relation to the enzymatic and nonenzymatic formation of conjugated hydroxy fatty acids.. Arch Biochem Biophys 1993;300:434-439.
  34. Diel P, Friedel A, Geyer H. Characterisation of the pharmacological profile of desoxymethyltestosterone (madol), a steroid misused for doping.. Toxicol Lett 2007;169:64-71.

Citations

This article has been cited 1 times.
  1. Pounina TA, Gloriozova TA, Savidov N, Dembitsky VM. Sulfated and Sulfur-Containing Steroids and Their Pharmacological Profile.. Mar Drugs 2021 Apr 24;19(5).
    doi: 10.3390/md19050240pubmed: 33923288google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.